Here’s Why the Media DOESN’T Stand Up to Big Pharma Greed as Drug Prices Skyrocket in US
In an Op-Ed published in The LA Times, Vermont Senator and former Democratic presidential candidate Bernie Sanders, penned:
“One out of five Americans age 19 to 64 cannot afford their prescriptions. Hundreds of thousands of seniors cut their pills in half to stretch one month’s prescription into two. Meanwhile, the five largest drug companies made more than $50 billion in profits last year.
“The top 10 CEOs in the industry received a total of more than $327 million in compensation. They [Big Pharma] currently have 1,266 lobbyists on their payrolls in Washington, D.C., and 118 fighting for their priorities in Sacramento. They’ve made hundreds of millions in campaign contributions to politicians.”
Though rising prescription drug prices is a major health crisis nationwide, corporate media largely ignored the issue important to millions of Americans.
Latest News from Ring Of Fire Radio/Drug Safety News
-
Bone Cement and Joint Prosthesis Failure
by Levin Papantio Law October 14, 2019
The bone cement used in knee replacement and other types of surgery has been associated with numerous intraoperative and post-operative complications, […]
-
Glyphosate Trials Delayed as Bayer Seeks Settlement
by Levin Papantio Law October 10, 2019
A number of glyphosate cancer cases that were scheduled to go to trial in the next several weeks have been postponed as Bayer AG attempts to reach a settlement […]
-
Hernia Mesh Infections: is it the Materials or Something Else?
by KJ McElr
One of the problems reported with hernia mesh has to do with the issue of biocompatibility between the materials used and human tissues. Surgical mesh (which […]
-
Major Drugmakers Issue Recalls for Zantac: Was NDMA "Built-In" to the Formula?
by Levin Papantio Law September 27, 2019
With this week's revelations of NDMA contamination in the popular antacid Zantac (ranitidine), health authorities and scientists are asking just how it […]
-
Losartan Recall Expanded
by KJ McElr
This week, the U.S. Food and Drug Administration expanded its recall of angiotensin II receptor blockers (ARBs) for the fifth time since last summer, when […]
-
FDA Says Cancer Risk From Contaminated ARBs Lower Than Previously Thought
by KJ McElr
In a statement published on August 28th, the FDA says that the cancer risk from contaminated angiotension II receptor blockers due to nitrosamine contamination […]
-
Bayer's Home Country Planning Glyphosate Ban
by Levin Papantio Law September 7, 2019
In the latest blow to German-based conglomerate Bayer, the government of Germany itself has now announced that it will begin phasing out allowed uses of […]
-
The Current Legal Troubles for the Future of JUUL and other Vaping Companies
by Levin Papantio Law August 30, 2019
No nation wants to fight a two-front war, although the U.S. and Germany both did it during the last century. Now, the e-cigarette industry finds itself in the […]
-
Talc Cancer Risk Spreads to Popular Cosmetics
by KJ McElr
As Johnson & Johnson continues to fight allegations that the talc in its Baby Powder contains cancer-causing asbestos, two cosmetics manufacturers have […]
-
Can Nexium and Prilosec Cause Greater Susceptibility to Allergies
by Levin Papantio Law August 23, 2019
The latest addition to a long list of risks and side effects associated with proton pump inhibitors is a predisposition to allergies, according to an Austrian […]
